Genzyme Corp - Company Profile
Powered by
All the data and insights you need on Genzyme Corp in one report.
- Save hours of research time and resources with
our up-to-date Genzyme Corp Strategy Report
- Understand Genzyme Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company developing specialty care treatments targeting rare diseases, oncology, rare blood disorders, immunology and multiple sclerosis. It offers products for the treatment of indications, including various forms of cancer, mucopolysaccharidosis I, multiple sclerosis, Gaucher disease type 1, long-term enzyme replacement therapy, acute lymphoblastic leukemia, atopic dermatitis, management of uric acid levels, fabry disease, rheumatoid arthritis, Pompe disease, non-Hodgkin's lymphoma, multiple myleoma, gastric adenocarcinoma and squamous cell carcinoma, among others. It operates a research and development lab and manufacturing plants in the US and other countries. Genzyme is headquartered in Cambridge, Massachusetts, the US.
Genzyme Corp premium industry data and analytics
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward